MUC16 and neoplasm: Since the detection limit of the assay is ± 5 U/ml and the vehicle-treated group had circulating CA125 levels of ∼700 U/ml, tumor burden was reduced by 200 fold or more in mice to undetectable levels after combined BHPI and paclitaxel treatment.